The Wnt signaling pathway in familial exudative vitreoretinopathy and norrie disease

Seminars in Ophthalmology

Volumn 22, Issue 4, 2007, Pages 211-217

  Warden, Scott M ^a   Andreoli, Christopher M ^a   Mukai, Shizuo ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Familial exudative vitreoretinopathy; Norrie disease; Retinal vasculopathy; Wnt pathway

Indexed keywords

GENE PRODUCT; NORRIN; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN INHIBITOR; WNT PROTEIN;

AUTOSOMAL RECESSIVE INHERITANCE; CILIARY DISK; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EXUDATIVE RETINITIS; FAMILIAL DISEASE; FAMILIAL EXUDATIVE VITREORETINOPATHY; GENE; GENE MUTATION; GENETIC COUNSELING; HUMAN; IRIS ATROPHY; LENSECTOMY; LEUKOKORIA; NDP GENE; NONHUMAN; NORRIE DISEASE; PERSISTENT FETAL VASCULAR SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA; RETINA DETACHMENT; RETINOBLASTOMA; RETINOSCHISIS; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VITRECTOMY; VITREORETINOPATHY; VITREOUS HEMORRHAGE; X CHROMOSOME LINKED DISORDER;

CATARACT; DEAFNESS; EXUDATES AND TRANSUDATES; GENETIC DISEASES, X-LINKED; HUMANS; MENTAL RETARDATION; RETINAL DISEASES; SIGNAL TRANSDUCTION; VITREORETINOPATHY, PROLIFERATIVE; WNT PROTEINS;

EID: 37549046071     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530701745124     Document Type: Review

References (65)

1. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982; 31(1):99-109.
2. Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D, Nusse R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987; 50(4):649-57.
3. McMahon AP, Moon RT. Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 1989; 58(6):1075-84.
4. Tao Q, Yokota C, Puck H, et al. Maternal Wnt11 activates the canonical Wnt signaling pathway required for axis formation in Xenopus embryos. Cell 2005; 120(6):857-71.
5. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127(3):469-80.
6. Kusserow A, Pang K, Sturm C, et al. Unexpected complexity of the Wnt gene family in a sea anemone. Nature 2005; 433(7022):156-60.
7. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781-810.
8. de Iongh RU, Abud HE, Hime GR. WNT/Frizzled signaling in eye development and disease. Front Biosci 2006; 11:2442-64.
9. Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003; 423(6938):448-52.
10. Bhanot P, Brink M, Samos CH, et al. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 1996; 382(6588):225-30.
11. Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J, Leahy DJ. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 2001; 412(6842):86-90.
12. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 2000; 407(6803):535-8.
13. Tamai K, Semenov M, Kato Y, et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000; 407(6803):530-5.
14. Wehrli M, Dougan ST, Caldwell K, et al. arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 2000; 407(6803):527-30.
15. Xu Q, Wang Y, Dabdoub A, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 2004; 116(6):883-95.
16. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. Embo J 1997; 16(13):3797-804.
17. Liu C, Kato Y, Zhang Z, Do VM, Yankner BA, He X. beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci USA 1999; 96(11):6273-8.
18. Latres E, Chiaur DS, Pagano M. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin. Oncogene 1999; 18(4):849-54.
19. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262(5140):1734-7.
20. Rubinfeld B, Souza B, Albert I, et al. Association of the APC gene product with beta-catenin. Science 1993; 262(5140):1731-4.
21. van de Wetering M, Cavallo R, Dooijes D, et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 1997; 88(6):789-99.
22. Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382(6592):638-42.
23. Molenaar M, van de Wetering M, Oosterwegel M, et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86(3):391-9.
24. Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol 1969; 68(4):578-94.
25. Laqua H. Familial exudative vitreoretinopathy. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1980; 213(2):121-33.
26. Canny CL, Oliver GL. Fluorescein angiographic findings in familial exudative vitreoretinopathy. Arch Ophthalmol 1976; 94(7):1114-20.
27. Gow J, Oliver GL. Familial exudative vitreoretinopathy. An expanded view. Arch Ophthalmol 1971; 86(2):150-5.
28. Tasman W, Augsburger JJ, Shields JA, Caputo A, Annesley WH, Jr. Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc 1981; 79:211-26.
29. Nijhuis FA, Deutman AF, Aan de Kerk AL. Flourescein angiography in mild stages of dominant exudative vitreoretinopathy. Mod Probl Ophthalmol 1979; 20:107-14.
30. Nishimura M, Yamana T, Sugino M, et al. Falciform retinal fold as sign of familial exudative vitreoretinopathy. Jpn J Ophthalmol 1983; 27(1):40-53.
31. van Nouhuys CE. Juvenile retinal detachment as a complication of familial exudative vitreoretinopathy. Fortschr Ophthalmol 1989; 86(3):221-3.
32. Bergen RL, Glassman R. Familial exudative vitreoretinopathy. Ann Ophthalmol 1983; 15(3):275-6.
33. de Crecchio G, Simonelli F, Nunziata G, et al. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin Genet 1998; 54(4):315-20.
34. Shastry BS, Hejtmancik JF, Plager DA, Hartzer MK, Trese MT. Linkage and candidate gene analysis of X-linked familial exudative vitreoretinopathy. Genomics 1995; 27(2):341-4.
35. Li Y, Muller B, Fuhrmann C, et al. The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533. Am J Hum Genet 1992; 51(4):749-54.
36. Downey LM, Keen TJ, Roberts E, Mansfield DC, Bamashmus M, Inglehearn CF. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13. Am J Hum Genet 2001; 68(3):778-81.
37. Toomes C, Downey LM, Bottomley HM, et al. Identification of a fourth locus (EVR4) for familial exudative vitreoretinopathy (FEVR). Mol Vis 2004; 10:37-42.
38. Toomes C, Downey LM, Bottomley HM, Mintz-Hittner HA, Inglehearn CF. Further evidence of genetic heterogeneity in familial exudative vitreoretinopathy; exclusion of EVR1, EVR3, and EVR4 in a large autosomal dominant pedigree. Br J Ophthalmol 2005; 89(2):194-7.
39. Robitaille J, MacDonald ML, Kaykas A, et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 2002; 32(2):326-30.
40. Toomes C, Bottomley HM, Jackson RM, et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet 2004; 74(4):721-30.
41. Qin M, Hayashi H, Oshima K, Tahira T, Hayashi K, Kondo H. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes. Hum Mutat 2005; 26(2):104-12.
42. Plager DA, Orgel IK, Ellis FD, Hartzer M, Trese MT, Shastry BS. X-linked recessive familial exudative vitreoretinopathy. Am J Ophthalmol 1992; 114(2):145-8.
43. Fullwood P, Jones J, Bundey S, Dudgeon J, Fielder AR, Kilpatrick MW. X linked exudative vitreoretinopathy: clinical features and genetic linkage analysis. Br J Ophthalmol 1993; 77(3):168-70.
44. Chen ZY, Battinelli EM, Fielder A, et al. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 1993; 5(2):180-3.
45. Jiao X, Ventruto V, Trese MT, Shastry BS, Hejtmancik JF. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5. Am J Hum Genet 2004; 75(5):878-84.
46. Warburg M. Norrie's disesae: differential diagnosis and treatment. Acta Ophthalmolol 1975; 53:217-36.
47. Warburg M. Norrie's disease. A congenital progressive oculoacustico-cerebral degeneration. Acta Ophthalmolol 1966; 89 Suppl:1-47.
48. Anderson S, Warburg M. Norrie's disease: congenital bilateral pseudotumor of the retina with X-chomosomal inheritance; preliminary report. Arch Ophthalmol 1961; 66:614-8.
49. Norrie G. Causes of blindness in children. Acta Ophthalmolol 1927; 5:357-86.
50. Andreoli C, Maumenee I, Zhu D, Mukai S. Histopathology and electron microscopy of a 16 week gestation retina carrying the norrie mutation. ARVO 2004.
51. Parsons MA, Curtis D, Blank CE, Hughes HN, McCartney AC. The ocular pathology of Norrie disease in a fetus of 11 weeks' gestational age. Graefes Arch Clin Exp Ophthalmol 1992; 230(3):248-51.
52. Joos KM, Kimura AE, Vandenburgh K, Bartley JA, Stone EM. Ocular findings associated with a Cys39Arg mutation in the Norrie disease gene. Arch Ophthalmol 1994; 112(12):1574-9.
53. Redmond RM, Vaughan JI, Jay M, Jay B. In-utero diagnosis of Norrie disease by ultrasonography. Ophthalmic Paediatr Genet 1993; 14(1):1-3.
54. Berger W, van de Pol D, Warburg M, et al. Mutations in the candidate gene for Norrie disease. Hum Mol Genet 1992; 1(7):461-5.
55. Schroeder B, Hesse L, Bruck W, Gal A. Histopathological and immunohistochemical findings associated with a null mutation in the Norrie disease gene. Ophthalmic Genet 1997; 18(2):71-7.
56. Michaelides M, Luthert PJ, Cooling R, Firth H, Moore AT. Norrie disease and peripheral venous insufficiency. Br J Ophthalmol 2004; 88(11):1475.
57. Chen ZY, Hendriks RW, Jobling MA, et al. Isolation and characterization of a candidate gene for Norrie disease. Nat Genet 1992; 1(3):204-8.
58. Berger W, Meindl A, van de Pol TJ, et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet 1992; 1(3):199-203.
59. Berger W, Rogers H. Norrie Disease. New York: McGraw Hill, 2001.
60. Dickinson JL, Sale MM, Passmore A, et al. Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity. Clin Experiment Ophthalmol 2006; 34(7):682-8.
61. Hiraoka M, Berinstein DM, Trese MT, Shastry BS. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J Hum Genet 2001; 46(4):178-81.
62. Black GC, Perveen R, Bonshek R, et al. Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet 1999; 8(11):2031-5.
63. Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 1997; 115(5):651-5.
64. Kim JH, Yu YS, Kim J, Park SS. Mutations of the Norrie gene in Korean ROP infants. Korean J Ophthalmol 2002; 16(2):93-6.
65. Haider MZ, Devarajan LV, Al-Essa M, et al. Missense mutations in norrie disease gene are not associated with advanced stages of retinopathy of prematurity in Kuwaiti arabs. Biol Neonate 2000; 77(2):88-91.